4.7 Article

Tumor-associated macrophages secrete CCL2 and induce the invasive phenotype of human breast epithelial cells through upregulation of ERO1-alpha and MMP-9

期刊

CANCER LETTERS
卷 437, 期 -, 页码 25-34

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2018.08.025

关键词

Tumor-associated macrophages (TAMs); Breast epithelial cells; ERO1-alpha; CCL2

类别

资金

  1. National Research Foundation of Korea [2013R1A2A2A04013379, 2015M3A9B6074045, 2016R1A6A1A03007648]

向作者/读者索取更多资源

Tumor-associated macrophages (TAMs) are major components of tumor microenvironment that promote invasion and metastasis of cancer cells. In this study, we investigated the effect of TAMs on phenotypic conversion of non-neoplastic MCF10A human breast epithelial cells using an indirect co-culture system. Co-culture with TAMs induced epithelial-to-mesenchymal transition, invasive phenotype, and MMP-9 upregulation in MCF10A cells. Comparative proteomic analysis revealed that endoplasmic reticulum oxidoreductase (ERO)1-alpha was increased in MCF10A cells co-cultured with TAMs compared to that in mono-cultured cells. ER01-a was crucial for TAMs-induced invasive phenotype and MMP-9 upregulation involving transcription factors c-fos and c-Jun. Cytokine array analysis showed that levels of interleukin (IL)-6, C-X-C motif ligand (CXCL)1, C-C motif ligand (CCL)2, growth-regulated protein (GRO), IL-8, and granulocyte-macrophage colony-stimulating factor (GM-CSF) were increased in conditioned media of co-cultured cells. Among these cytokines increased in conditioned media of co-cultured cells, CCL2 was secreted from TAMs, leading to induction of ERO1-alpha, MMP-9 upregulation, and invasiveness in MCF10A cells. Our findings elucidated a molecular mechanism underlying the aggressive phenotypic change of non-neoplastic breast cells by co-culture with TAMs, providing useful information for prevention or treatment of recurrent breast cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medical Laboratory Technology

Cytologic diagnosis of medullary thyroid carcinoma in theAsia-Pacificregion

Chih-Yi Liu, Andrey Bychkov, Shipra Agarwal, Yun Zhu, Jen-Fan Hang, Chiung-Ru Lai, Hee Young Na, Weiwei Li, Zhiyan Liu, Deepali Jain, Ayana Suzuki, Mitsuyoshi Hirokawa, Noel Chia, Min En Nga, Tikamporn Jitpasutham, Somboon Keelawat, So Yeon Park, Shinya Satoh, Chien-Chin Chen, Dilini Gunawardena, Priyanthi Kumarasinghe, Chan Kwon Jung, Kennichi Kakudo

Summary: This study summarizes the handling of MTC in contemporary Asian thyroid FNA practice. Although the detection rate of MTC by cytology alone is less satisfactory, integration with ancillary tests could achieve an excellent performance. Recognition of constitutive cytomorphologic features is necessary for each cytopreparatory method, which may lead to a lower threshold for further MTC workup.

DIAGNOSTIC CYTOPATHOLOGY (2021)

Article Pathology

Application of the Bethesda System for Reporting Thyroid Cytopathology in the Pediatric Population A Multicenter Study in Asian Countries

Huy Gia Vuong, Ayana Suzuki, Hee Young Na, Pham Van Tuyen, Doan Minh Khuy, Hiep Canh Nguyen, Tikamporn Jitpasutham, Agustina Abelardo, Takashi Amano, So Yeon Park, Chan Kwon Jung, Mitsuyoshi Hirokawa, Ryohei Katoh, Kennichi Kakudo, Andrey Bychkov

Summary: In this study, the Asian pediatric thyroid nodules had a higher resection rate and risk of malignancy compared to adults, suggesting the need for adjustments to TBSRTC in the pediatric population.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)

Article Oncology

Genomic Alterations during the In Situ to Invasive Ductal Breast Carcinoma Transition Shaped by the Immune System

Anne Trinh, Carlos R. Gil Del Alcazar, Sachet A. Shukla, Koei Chin, Young Hwan Chang, Guillaume Thibault, Jennifer Eng, Bojana Jovanovic, C. Marcelo Aldaz, So Yeon Park, Joon Jeong, Catherine Wu, Joe Gray, Kornelia Polyak

Summary: The transition from DCIS to IDC involves genetic correlations despite long latency periods and therapeutic interventions. Immune hot and cold tumors can arise early in DCIS, with different degrees of immune cell mixing between DCIS and IDC. Tumor-specific copy-number aberrations and mutations are associated with differences in immune signaling in IDC, potentially modulating immune function and driving the transition to IDC.

MOLECULAR CANCER RESEARCH (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

False-negative results on computer-aided detection software in preoperative automated breast ultrasonography of breast cancer patients

Youngjune Kim, Jiwon Rim, Sun Mi Kim, Bo La Yun, So Yeon Park, Hye Shin Ahn, Bohyoung Kim, Mijung Jang

Summary: The study found that CAD software has a high detection rate for breast cancer, but it has a low positive predictive value and a high false positive rate. False-negative results are common in asymptomatic patients and are associated with specific ultrasound findings.

ULTRASONOGRAPHY (2021)

Article Oncology

A Real-World Efficacy of Nab-Paclitaxel Monotherapy in Metastatic Breast Cancer

Jung Sun Kim, Koung Jin Suh, Dae-Won Lee, Go-Un Woo, Miso Kim, Se Hyun Kim, Han Suk Ryu, Kyung-Hun Lee, Tae-Yong Kim, Sae-Won Han, So Yeon Park, In Ae Park, Jee Hyun Kim, Seock-Ah Im

Summary: This study aimed to assess the real-world efficacy of nab-paclitaxel in metastatic breast cancer patients. The results showed that nab-paclitaxel is a reasonable treatment option for heavily pre-treated and/or taxane-exposed patients with metastatic breast cancer.

CANCER RESEARCH AND TREATMENT (2022)

Article Endocrinology & Metabolism

Expression of CYP11B1 and CYP11B2 in adrenal adenoma correlates with clinical characteristics of primary aldosteronism

Chang Ho Ahn, Hee Young Na, So Yeon Park, Hyeong Won Yu, Su-Jin Kim, June Young Choi, Kyu Eun Lee, Sang Wan Kim, Kyeong Cheon Jung, Jung Hee Kim

Summary: Variable expression of steroidogenic enzymes in adrenal adenoma underlies the clinical heterogeneity of PA and is associated with treatment outcomes. CYP11B1 expression was positively correlated with the severity of hypercortisolemia, and CYP11B2 was positively correlated with that of hyperaldosteronism. Patients with absent clinical improvement after adrenalectomy had lower CYP11B2 expression than those with complete success.

CLINICAL ENDOCRINOLOGY (2022)

Article Pathology

A multicenter study of interobserver variability in pathologic diagnosis of papillary breast lesions on core needle biopsy with WHO classification

Hye Ju Kang, Sun Young Kwon, Ahrong Kim, Woo Gyeong Kim, Eun Kyung Kim, Ae Ree Kim, Chungyeul Kim, Soo Kee Min, So Young Park, Sun Hee Sung, Hye Kyoung Yoon, Ahwon Lee, Ji Shin Lee, Hyang Im Lee, Ho Chang Lee, Sung Chul Lim, Sun Young Jun, Min Jung Jung, Chang Won Jung, Soo Youn Cho, Eun Yoon Cho, Hye Jeong Choi, So Yeon Park, Jee Yeon Kim, In Ae Park, Youngmee Kwon

Summary: The study investigated diagnostic reproducibility of papillary breast lesions (PBLs) in core needle biopsy (CNB) specimens using World Health Organization (WHO) classification. Results showed discrepancies in diagnostic agreement with WHO classification, despite improvements with simplifying classifications and immunohistochemical staining for CK5 and p63. Further intensive consensus studies are needed to enhance the diagnostic reproducibility of PBLs with WHO classification.

JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2021)

Article Endocrinology & Metabolism

Clinicopathological indicators for TERT promoter mutation in papillary thyroid carcinoma

Hee Young Na, Hyeong Won Yu, Woochul Kim, Jae Hoon Moon, Chang Ho Ahn, Sang Il Choi, Yeo Koon Kim, June Young Choi, So Yeon Park

Summary: This study reveals a relatively low frequency of TERT promoter mutations in Korean patients with PTC. Certain clinicopathological features including old age, tall cell variant, increased mitoses, tumour necrosis, and gross extrathyroidal extension were found to be indicative of TERT promoter mutations in PTCs.

CLINICAL ENDOCRINOLOGY (2022)

Article Oncology

miR-145, miR-205 and miR-451: potential tumor suppressors involved in the progression of in situ to invasive carcinoma of the breast

Ji Won Woo, Hye Yeon Choi, Milim Kim, Yul Ri Chung, So Yeon Park

Summary: This study identified miR-145, miR-205, and miR-451 as down-regulated miRNAs in invasive breast cancer (IBC) compared to ductal carcinoma in situ (DCIS). Furthermore, their expression levels were lower in high-risk DCIS cases and correlated with various clinicopathological features. These miRNAs may play a role as tumor suppressors in the progression of DCIS to invasive carcinoma.

BREAST CANCER (2022)

Review Pathology

Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: its updated diagnostic criteria, preoperative cytologic diagnoses and impact on the risk of malignancy

Hee Young Na, So Yeon Park

Summary: NIFTP, reclassified as a non-cancerous thyroid neoplasm, has impacted the evaluation of malignancy risk in thyroid diseases through changes in diagnostic criteria, incidence, and preoperative cytologic diagnoses.

JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2022)

Article Oncology

Development and External Validation of a Machine Learning Model to Predict Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer

Ji-Jung Jung, Eun-Kyu Kim, Eunyoung Kang, Jee Hyun Kim, Se Hyun Kim, Koung Jin Suh, Sun Mi Kim, Mijung Jang, Bo La Yun, So Yeon Park, Changjin Lim, Wonshik Han, Hee-Chul Shin

Summary: A machine learning model was developed and externally validated to predict pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) in breast cancer patients using routinely collected clinical and demographic variables. The model was trained and internally validated using patient data from Seoul National University Bundang Hospital, and five machine learning techniques were used to compare the predictive performance. The model was then externally validated using an independent cohort from Seoul National University Hospital.

JOURNAL OF BREAST CANCER (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

The Value of Adding Ductography to Ultrasonography for the Evaluation of Pathologic Nipple Discharge in Women with Negative Mammography

Younjung Choi, Sun Mi Kim, Mijung Jang, Bo La Yun, Eunyoung Kang, Eun-Kyu Kim, So Yeon Park, Bohyoung Kim, Nariya Cho, Woo Kyung Moon

Summary: Combining ductography and ultrasound (US) has a high sensitivity for detecting malignancy in patients with pathological nipple discharge and negative mammography, and it enables lesion localization for optimal treatment plans.

KOREAN JOURNAL OF RADIOLOGY (2022)

Article Oncology

Prognostic significance of S100A8-positive immune cells in relation to other immune cell infiltration in pre-invasive and invasive breast cancers

Ji Won Woo, Yul Ri Chung, Milim Kim, Hye Yeon Choi, Soomin Ahn, So Yeon Park

Summary: MDSCs play a crucial role in tumor progression through immunologic and non-immunologic mechanisms, with the marker S100A8 showing significant expression in pre-invasive and invasive breast cancers. The infiltration of S100A8+ immune cells was associated with a poorer prognosis in both early and invasive carcinomas, especially in hormone receptor-positive subgroups. Additionally, the infiltration of other immune cell subsets was higher in S100A8+ immune cell (+) group, indicating a complex interaction between different immune cell populations in breast cancer progression.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Review Oncology

Standardized Pathology Report for Breast Cancer

Soo Youn Cho, So Yeon Park, Young Kyung Bae, Jee Yeon Kim, Eun Kyung Kim, Woo Gyeong Kim, Youngmee Kwon, Ahwon Lee, Hee Jin Lee, Ji Shin Lee, Jee Young Park, Gyungyub Gong, Hye Kyoung Yoon

Summary: The Breast Pathology Study Group of the Korean Society of Pathologists has developed a standardized pathology reporting format for breast cancer, comprising 'standard data elements,' 'conditional data elements,' and a biomarker report form. It is expected that this standardized pathology report will improve diagnostic concordance and communication between pathologists and clinicians, as well as between pathologists inter-institutionally.

JOURNAL OF BREAST CANCER (2021)

Review Oncology

Small extracellular vesicles: Non-negligible vesicles in tumor progression, diagnosis, and therapy

Xinru Zhou, Yin Jia, Chuanbin Mao, Shanrong Liu

Summary: Small extracellular vesicles (sEVs), such as exosomes, have emerged as crucial targets for liquid biopsy and promising drug delivery vehicles in tumor progression. They can serve as biomarkers for tumor diagnosis and as drug carriers for cancer treatment.

CANCER LETTERS (2024)

Article Oncology

HMGB1 in the interplay between autophagy and apoptosis in cancer

Ruochan Chen, Ju Zhu, Xiao Zhong, Jie Li, Rui Kang, Daolin Tang

Summary: The interplay between autophagy and apoptosis plays a crucial role in tumorigenesis and cancer therapy, with HMGB1 serving as a key regulator in these processes.

CANCER LETTERS (2024)

Article Oncology

Epigenetic inhibition of CTCF by HN1 promotes dedifferentiation and stemness of anaplastic thyroid cancer

Zongfu Pan, Xixuan Lu, Tong Xu, Jinming Chen, Lisha Bao, Ying Li, Yingying Gong, Yulu Che, Xiaozhou Zou, Zhuo Tan, Ping Huang, Minghua Ge

Summary: This study uncovered the emerging role of HN1 in promoting dedifferentiation of anaplastic thyroid cancer (ATC) cells. HN1 negatively regulated the thyroid differentiation markers and had an inhibitory effect on the transcriptional activation of CTCF, thereby influencing the chromatin accessibility of thyroid differentiation genes.

CANCER LETTERS (2024)

Article Oncology

Autophagy machinery in glioblastoma: The prospect of cell death crosstalk and drug resistance with bioinformatics analysis

Yi Qin, Shengjun Xiong, Jun Ren, Gautam Sethi

Summary: Autophagy plays an important regulatory role in glioblastoma, and its dysregulation can lead to drug resistance and radioresistance. It also affects stem cell characteristics, overall growth, and metastasis. Therefore, autophagy is a promising target for glioblastoma therapy.

CANCER LETTERS (2024)

Article Oncology

Elevated 2-oxoglutarate antagonizes DNA damage responses in cholangiocarcinoma chemotherapy through regulating aspartate beta-hydroxylase

Katsuya Nagaoka, Xuewei Bai, Dan Liu, Kevin Cao, Joud Mulla, Chengcheng Ji, Hongze Chen, Muhammad Azhar Nisar, Amalia Bay, William Mueller, Grace Hildebrand, Jin-Song Gao, Shaolei Lu, Hiroko Setoyama, Yasuhito Tanaka, Jack R. Wands, Chiung-Kuei Huang

Summary: This study found that serum 2-OG levels in cholangiocarcinoma patients are associated with the effectiveness of chemotherapy. Patients with progressive disease showed significantly higher levels of serum 2-OG compared to stable disease and partial response patients. The study also revealed that overexpression of ASPH mimics the effects of 2-OG, and knockdown of ASPH improves chemotherapy. Targeting ASPH enhances the effects of chemotherapy by modulating ATM and ATR, two key regulators of DDRs.

CANCER LETTERS (2024)